Patient Registry Software Market Set for Strong Growth to USD 5.01 Billion by 2031, Led by North America's 48.6% Global Market Share | DataM Intelligence

The Global Patient Registry Software Market was valued at USD 1.71 billion in 2023 and is projected to reach USD 5.01 billion by 2031, growing at a CAGR of 9.2% during the forecast period 2024-2031.

Market expansion is fueled by the rising demand for real-world evidence in clinical research, increasing adoption of electronic health records, and regulatory mandates for data interoperability. Advancements in cloud-based deployment, growing prevalence of chronic diseases like cancer and diabetes, and investments in healthcare IT further propel growth, particularly in North America which holds the largest share.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/patient-registry-software-market?ram

United States: Key Industry Developments
✅ December 2025: The U.S. patient registry software market reached USD 776.28 million, driven by advanced healthcare IT infrastructure and demand for real-world evidence in chronic disease management and value-based care.​

✅ October 2025: Registry Partners launched RegiHealth, a new program designed to optimize healthcare registries and maximize returns on patient registry investments for providers.​

✅ August 2025: Oracle introduced a modern AI-powered Electronic Health Record (EHR) system for U.S. ambulatory providers, enhancing care quality with contextual intelligence and voice-activated data access that supports registry integration.​

Asia Pacific / Japan: Key Industry Developments
✅ January 2025: India launched a national rare disease patient registry to improve diagnosis, care coordination, and data collection amid rising demand for specialized health tracking solutions.​

✅ July 2025: Japan's patient registry software market advanced with increased adoption of AI, machine learning, and cloud technologies, fueled by an aging population and government digitization efforts for chronic disease monitoring.​

✅ May 2025: Asia Pacific saw accelerated growth in patient registry software through healthcare IT investments and regulatory reforms in countries like China, India, and Japan, emphasizing real-world evidence for clinical research.​

Key Merges and Acquisitions(2025):
✅ Leading providers in the patient registry software market enhanced their data management capabilities through strategic acquisitions of specialized software platforms, improving interoperability and scalability.

✅ Major software firms strengthened their healthcare portfolios by acquiring innovative registry technology developers, expanding cloud-based solutions and AI-driven analytics.

✅ Key players collaborated on mergers integrating patient registry systems with advanced electronic health record platforms to meet rising demands for real-world evidence generation.​

Market Segmentation Analysis:
-By Disease Registry Type
Cardiovascular registries lead with 26% share, driven by large chronic patient pools and payer focus on outcomes in heart disease management.​
Diabetes accounts for 18%, supported by rising global prevalence and need for longitudinal tracking of glycemic control and complications.​
Cancer registries hold 17% as oncology centers deploy rich datasets for clinical decision support and trial recruitment.​
Orthopaedics captures 12%, used to monitor implants, joint replacements, and longer‐term functional outcomes.​
Alzheimer's disease represents 9%, reflecting growing neurodegenerative research and need for cognitive decline tracking.​
Others (rare, renal, asthma, etc.) collectively take 18%, aggregating multiple smaller disease‐specific programs.​

-By Functionality Type
Patient care management dominates at 38%, as providers rely on registries to manage cohorts, stratify risk, and track quality indicators in routine care.​
Research functionality holds 27%, supporting observational studies, outcomes research, and post‐marketing evidence generation.​
Health information exchange (HIE) contributes 21%, integrating data from EMRs, labs, and claims to build longitudinal patient views.​
Point of care (POC) accounts for 14%, enabling real‐time prompts and decision support at the clinician interface.​

-By End User
Hospitals lead with 41%, using registries for quality reporting, accreditation, and value‐based care contracts.​
Pharmaceutical companies hold 34%, leveraging real‐world data for drug safety, effectiveness, and label‐expansion strategies.​
Clinical laboratories account for 25%, aggregating high‐volume test data into registries for disease surveillance and companion diagnostics.​

-By Software Type
Integrated software dominates with 63% share, preferred for seamless interoperability with EHRs, billing, and analytics platforms.​
Stand‐alone solutions hold 37%, chosen by niche programs and smaller organizations needing focused, lower‐complexity deployments.​

Purchase this report before year-end and unlock an exclusive 30% discount: https://www.datamintelligence.com/buy-now-page?report=patient-registry-software-market?ram (Purchase 2 or more Reports and get 50% Discount)

Why is the Patient Registry Software Market Growing?
The rapid expansion of the Patient Registry Software market in 2026 is fueled by several critical factors:​

-Surging Demand for Real-World Evidence: The growing need for real-world evidence (RWE) in regulatory decisions, value-based care, and post-market surveillance is boosting adoption, particularly for chronic and rare diseases.​

-Cloud-Based Deployment Surge: Cloud solutions lead growth with high CAGRs due to scalability, cost-effectiveness, real-time access, and easier interoperability across healthcare networks.​

-EHR Integration and Interoperability: Increased electronic health record (EHR) adoption and mandatory standards enable seamless data flow, reducing errors and supporting population health management.​

-AI and Analytics Advancements: AI-driven tools for data analysis, automation, and insights from unstructured data enhance accuracy, predictive capabilities, and research efficiency.

Regional Insights:
-North America leads the Patient Registry Software Market with the highest share at approximately 48.6% as of 2025, driven by advanced healthcare IT infrastructure, widespread electronic health record adoption, and strong government support for chronic disease surveillance and real-world evidence programs.​

-Europe follows as the second-largest region, benefiting from established national registry initiatives, high predictive analytics accuracy, and collaborations among key players that enhance software adoption for clinical research and population health management.​

-Asia Pacific ranks third in market share, showing the fastest growth potential with a projected CAGR of 10.6% through 2035, fueled by government-led digital health record initiatives and rising demand for value-based patient care in emerging economies.​

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/patient-registry-software-market?ram

Key Players:
Dacima Software Inc. | McKesson Corporation | Global Vision Technologies Inc. | ImageTrend Inc. | Liaison Technologies | Optum Inc. | Phytel Inc. | Quintiles IMS Holdings Inc.

Key Highlights (Top 5 Key Players) for Patient Registry Software Market:
-Dacima Software Inc. develops cloud-based platforms for customizable patient registries, enabling data collection, management, and analytics for clinical research and population health studies.

-McKesson Corporation provides integrated registry solutions within its healthcare IT ecosystem, focusing on secure data aggregation, interoperability with EHRs, and quality improvement tracking for hospitals and providers.

-Global Vision Technologies Inc. offers scalable registry software tailored for chronic disease management and rare conditions, with features for real-time reporting, regulatory compliance, and multi-site collaboration.

-ImageTrend Inc. specializes in incident and patient registry tools for emergency services and public health, supporting data visualization, outcome analysis, and integration across pre-hospital and long-term care workflows.

-Optum Inc. delivers advanced analytics-driven registry platforms as part of UnitedHealth Group, emphasizing population health management, risk stratification, and value-based care through AI-enhanced insights and FHIR-compliant data exchange.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?ram

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.